Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Human Vaccines & Immunotherapeutics|November 12, 2020
Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?Laura Sticchi, Lucia Taramasso, Antonio Di Biagio, et al.
Igiene E Sanita Pubblica|September 23, 2010
[Novel approaches for the prevention of influenza: the intradermal vaccination]Paolo Durando, Laura Sticchi, Marisa Alberti, et al.
Clinical and Vaccine Immunology : CVI|January 24, 2006
Neutralizing and hemagglutination-inhibiting activities of antibodies elicited by the 2004-2005 influenza vaccine against drifted virusesFilippo Ansaldi, Sabrina Bacilieri, Federica Banfi, et al.
European Journal of Haematology|March 27, 2003
Influenza vaccine in chronic lymphoproliferative disorders and multiple myelomaDavide Rapezzi, Laura Sticchi, Omar Racchi, et al.
Vaccine|May 4, 2010
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolatesFilippo Ansaldi, Marta Zancolli, Paolo Durando, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2023
Safety of anti-varicella zoster virus vaccination in patients with multiple sclerosis treated with natalizumab: A case seriesCaterina Lapucci, Vincenzo Daniele Boccia, Tommaso Sirito, et al.
Recent Patents on Anti-Infective Drug Discovery|July 18, 2014
Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy?Antonio Di Biagio, Roberta Prinapori, Lucia Taramasso, et al.
The New Microbiologica|May 20, 2016
HIV-1 RNA quantification in CRF02_AG HIV-1 infection: too easy to make mistakesPaola Tatarelli, Lucia Taramasso, Antonio Di Biagio, et al.
Vaccine|February 10, 2009
Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patientsMaurizio Setti, Daniela Fenoglio, Filippo Ansaldi, et al.
Vaccine|February 26, 2008
Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza virusesFilippo Ansaldi, Sabrina Bacilieri, Paolo Durando, et al.
Pageof 6